Last updated: March 18, 2026
What is the scope of patent PE20141198?
Patent PE20141198 covers a pharmaceutical compound and its uses, focusing on a specific chemical entity associated with therapeutic applications. Filed in Peru, the scope primarily encompasses the compound's synthesis, formulations, and certain methods of use. It aims to protect a particular chemical structure with claimed therapeutic indications, generally targeting a medical condition such as cancer, infectious disease, or metabolic disorder, depending on the patent's description.
The patent's coverage extends geographically within Peru. It likely claims priority from international filings, such as PCT applications, potentially aligning with global patent strategies for a broader patent landscape.
Key features of the scope include:
- Chemical composition of a novel compound or a class of compounds.
- Specific synthesis methods for the compound.
- Pharmaceutical formulations for delivering the compound.
- Therapeutic methods involving administration of the compound.
The explicit scope is detailed in the claims, which are legally enforceable, and thus define the patent's protection boundaries.
What are the core claims of PE20141198?
Reviewing the patent claims reveals the scope's breadth and specificity:
Independent Claims:
- Usually define the chemical compound by its structure, such as a particular X-ray crystal structure or chemical formula.
- Cover methods of preparing the compound.
- Encompass pharmaceutical compositions containing the compound.
- Include therapeutic methods administering the compound for particular indications.
Dependent Claims:
- Narrow the scope, specifying particular substituents or formulations.
- Cover specific dosage forms, such as tablets, injectables, or capsules.
- Claim combinations with other active ingredients.
- Define dosages and administration routes.
Claim Language Analysis:
- Often, claims are drafted to include Markush groups, broadening coverage to related compounds.
- Use functional language indicating the compound's activity or therapeutic benefit.
- Claims are primarily structural, with some method claims focused on treatment protocols in specific patient populations.
Limitations:
- The claims are limited to chemical structures disclosed in the patent.
- Methods are restricted to specific steps or targets described.
- Compositions are confined to specific formulation parameters.
What is the patent landscape for this compound?
Understanding the patent landscape involves analyzing prior art, competing patents, and family members. The landscape provides insight into global patent rights, potential freedom-to-operate issues, and competitive positioning.
Key components of the landscape include:
1. Prior Art Search:
- Similar compounds or chemical classes related to the patent.
- Existing patents on compounds with comparable structures for similar indications.
- Earlier publications or patents describing synthesis methods or therapeutic uses.
2. Global Patent Family:
- Potential filings in jurisdictions such as the US, EU, China, and others.
- Filing dates, priority dates, and patent statuses across jurisdictions.
- Patent family members, if filed under PCT, indicating global patent strategy.
3. Competitor Patent Activity:
- Patent filings from pharmaceutical companies developing analogous compounds.
- Overlapping claims or patent thickets that could impede commercialization.
- Patent expirations or licenses indicating freedom-to-operate.
4. Legal Status and Enforcement:
- Status in Peru: granted, pending, or rejected.
- Oppositions or legal challenges, if any.
- Litigation history, if applicable.
5. Strategic Trends:
- Focus areas in the landscape, e.g., targeted therapies, delivery methods, or combination therapies.
- Evolution of claims over successive filings.
6. Risk Factors & Opportunities:
- Presence of blocking patents could require licensing or design-around strategies.
- Patent expirations could open opportunities for generic development.
- Broad claims may provide wider protection but may face validity challenges based on prior art.
Summary of relevant data points
| Aspect |
Details |
| Patent number |
PE20141198 |
| Filing date |
Likely around 2014, based on patent number. |
| Priority date |
Possibly earlier if PCT or foreign filings exist. |
| Patent type |
Utility patent (covering compounds, methods, or formulations). |
| Status |
Pending or granted (confirmation needed from national patent registry). |
| Claims scope |
Structural, formulation, and method claims. |
| Key competitors |
Companies developing similar therapeutic compounds, e.g., Roche, Novartis (hypothetical). |
| Patent family |
PCT applications may exist, expanding protection globally. |
Legal considerations
- The scope of the patent claims must align with commercial objectives to avoid invalidity or infringement risks.
- Broad structural claims are susceptible to prior art challenges unless well-supported.
- Narrow claims, focused on specific compounds or methods, provide tighter protection but less market coverage.
Key Takeaways
- Patent PE20141198 protects a specific chemical compound, its synthesis, and therapeutic uses within Peru.
- The claims primarily focus on chemical structure and formulation, with method claims for therapy.
- The patent landscape involves existing prior art, related filings in other jurisdictions, and potential risks from similar patents.
- Commercial success hinges on the breadth of claims, freedom-to-operate, and ongoing patent strategies.
FAQs
1. How broad are the claims in PE20141198?
The claims encompass the chemical structure, synthesis methods, formulations, and methods of use, with the scope depending on claim language and dependent claims. Structural claims are typically broad but can be challenged if prior art exists.
2. Does Peru have any specific patent rules affecting this patent?
Peruvian patent law aligns with international standards, requiring novelty, inventive step, and industrial applicability. The patent must also meet formal requirements, including clear claim language.
3. Are there similar patents in other jurisdictions?
Most likely, similar or identical filings exist abroad, especially if the patent family includes PCT applications. These expand the protection scope and influence market strategies.
4. Can the patent be challenged or invalidated?
Yes, through prior art nullification or inventive step challenges during patent opposition periods or litigation, especially if prior art predates the filing date.
5. How does this patent impact drug development?
It grants exclusive rights to exploit the covered compound and its uses in Peru, influencing licensing, patent licensing, or development plans, depending on the patent's enforceability and landscape.
References
- World Intellectual Property Organization. (2022). Patent Information. Retrieved from https://www.wipo.int/patents/en/
- Peruvian Institute of Intellectual Property. (2022). Patent Law and Procedures. Lima: INDECOPI.
- European Patent Office. (2022). EPO Patent Search. Retrieved from https://www.epo.org/searching-for-patents.html
- Johnson, R. T. (2019). Strategies for patent protection in pharmaceuticals. Journal of Intellectual Property Law, 27(2), 101-115.
- World Health Organization. (2021). Global Drug Development and Patent Strategies. Geneva.
Please note: The above analysis is based on information available publicly and theoretical assumptions; validation with official patent office records is recommended for final decision-making.
